Toward the industrialization of gene therapies -Polytheragene
Polytheragene is developing a polymer that will improve upon the current market standards for the production of viral particles for therapeutics. The polymer will be used by Genethon and Yposkesi to enhance the bioproduction of gene therapy vectors.
26 March 2020Read the article
Jean Weissenbach: a portrait
Jean Weissenbach, a pioneer in France for the exploration of the human genome and a scientific icon at Genopole, talks about his career in an interview published 18 March 2020 in CNRS News.
24 March 2020Read the article
A nanopore to identify amino acids – Lambe
A team from the Laboratory for Analysis and Modeling in Biology and the Environment (Lambe – University of Évry/University of Cergy-Pontoise/CNRS) used a natural aerolysin nanopore to successfully identify 13 of the 20 amino acids that make up proteins.
20 February 2020Read the article
Green light from Europe for the Genopole-coordinated project GEN.ERA
Le projet européen GEN.ERA*, coordonné par Genopole, est sélectionné par la Commission européenne. Il vise à renforcer par une coopération entre clusters, l’internationalisation d’entreprises du secteur de la génomique au-delà du continent européen.
14 February 2020Read the article
New accomplishment in gene therapies
A clinical trial for a gene therapy to treat a severe immunodeficiency has provided highly promising initial results.
28 January 2020Read the article